303 related articles for article (PubMed ID: 26743871)
1. Kv10.1 K(+) channel: from physiology to cancer.
Ouadid-Ahidouch H; Ahidouch A; Pardo LA
Pflugers Arch; 2016 May; 468(5):751-62. PubMed ID: 26743871
[TBL] [Abstract][Full Text] [Related]
2. Kv10.1 potassium channel: from the brain to the tumors.
Cázares-Ordoñez V; Pardo LA
Biochem Cell Biol; 2017 Oct; 95(5):531-536. PubMed ID: 28708947
[TBL] [Abstract][Full Text] [Related]
3. Eag1 K
Han B; Tokay T; Zhang G; Sun P; Hou S
Oxid Med Cell Longev; 2017; 2017():7371010. PubMed ID: 28367272
[No Abstract] [Full Text] [Related]
4. KV10.1 K(+)-channel plasma membrane discrete domain partitioning and its functional correlation in neurons.
Jiménez-Garduño AM; Mitkovski M; Alexopoulos IK; Sánchez A; Stühmer W; Pardo LA; Ortega A
Biochim Biophys Acta; 2014 Mar; 1838(3):921-31. PubMed ID: 24269539
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the K
Barriga-Montoya C; Huanosta-Gutiérrez A; Reyes-Vaca A; Hernández-Cruz A; Picones A; Gómez-Lagunas F
Pflugers Arch; 2018 Mar; 470(3):491-503. PubMed ID: 29218452
[TBL] [Abstract][Full Text] [Related]
6. Procyanidin B1, a novel and specific inhibitor of Kv10.1 channel, suppresses the evolution of hepatoma.
Na W; Ma B; Shi S; Chen Y; Zhang H; Zhan Y; An H
Biochem Pharmacol; 2020 Aug; 178():114089. PubMed ID: 32533968
[TBL] [Abstract][Full Text] [Related]
7. Periodic expression of Kv10.1 driven by pRb/E2F1 contributes to G2/M progression of cancer and non-transformed cells.
Urrego D; Movsisyan N; Ufartes R; Pardo LA
Cell Cycle; 2016; 15(6):799-811. PubMed ID: 27029528
[TBL] [Abstract][Full Text] [Related]
8. Dronedarone blockage of the tumor-related Kv10.1 channel: a comparison with amiodarone.
Meléndez TA; Huanosta-Gutiérrez A; Barriga-Montoya C; González-Andrade M; Gómez-Lagunas F
Pflugers Arch; 2020 Jan; 472(1):75-87. PubMed ID: 31897736
[TBL] [Abstract][Full Text] [Related]
9. Ether-à-go-go K
Bauer CK; Schwarz JR
J Physiol; 2018 Mar; 596(5):769-783. PubMed ID: 29333676
[TBL] [Abstract][Full Text] [Related]
10. Alternatively Spliced Isoforms of KV10.1 Potassium Channels Modulate Channel Properties and Can Activate Cyclin-dependent Kinase in Xenopus Oocytes.
Ramos Gomes F; Romaniello V; Sánchez A; Weber C; Narayanan P; Psol M; Pardo LA
J Biol Chem; 2015 Dec; 290(51):30351-65. PubMed ID: 26518875
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of tumour xenografts with an antibody targeting the potassium channel K
Napp J; Pardo LA; Hartung F; Tietze LF; Stühmer W; Alves F
Eur Biophys J; 2016 Oct; 45(7):721-733. PubMed ID: 27444284
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional and post-transcriptional mechanisms for oncogenic overexpression of ether à go-go K+ channel.
Lin H; Li Z; Chen C; Luo X; Xiao J; Dong D; Lu Y; Yang B; Wang Z
PLoS One; 2011; 6(5):e20362. PubMed ID: 21655246
[TBL] [Abstract][Full Text] [Related]
13. Cyclic expression of the voltage-gated potassium channel KV10.1 promotes disassembly of the primary cilium.
Sánchez A; Urrego D; Pardo LA
EMBO Rep; 2016 May; 17(5):708-23. PubMed ID: 27113750
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine inhibits tumor-related Kv10.1 channel and decreases migration of MDA-MB-231 breast cancer cells in vitro.
Valdés-Abadía B; Morán-Zendejas R; Rangel-Flores JM; Rodríguez-Menchaca AA
Eur J Pharmacol; 2019 Jul; 855():262-266. PubMed ID: 31082369
[TBL] [Abstract][Full Text] [Related]
15. Eag1 Gene and Protein Expression in Human Retinoblastoma Tumors and its Regulation by pRb in HeLa Cells.
Chávez-López MG; Zúñiga-García V; Castro-Magdonel BE; Vera E; Garrido E; Sánchez-Ramos J; Ponce-Castañeda MV; Cabrera-Muñoz ML; Escobar Y; Ortiz CS; Hernández-Gallegos E; Avalos-Fuentes A; Camacho J
Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 31973216
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival.
Martínez R; Stühmer W; Martin S; Schell J; Reichmann A; Rohde V; Pardo L
BMC Cancer; 2015 Nov; 15():839. PubMed ID: 26530050
[TBL] [Abstract][Full Text] [Related]
17. Thallium-sensitive fluorescent assay reveals loperamide as a new inhibitor of the potassium channel Kv10.1.
Loza-Huerta A; Milo E; Picones A; Hernández-Cruz A; Luis E
Pharmacol Rep; 2021 Dec; 73(6):1744-1753. PubMed ID: 34213738
[TBL] [Abstract][Full Text] [Related]
18. Gating Modulation of the Tumor-Related Kv10.1 Channel by Mibefradil.
Gómez-Lagunas F; Carrillo E; Pardo LA; Stühmer W
J Cell Physiol; 2017 Aug; 232(8):2019-2032. PubMed ID: 27255432
[TBL] [Abstract][Full Text] [Related]
19. Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of K
Toplak Ž; Merzel F; Pardo LA; Peterlin Mašič L; Tomašič T
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445705
[TBL] [Abstract][Full Text] [Related]
20. The punctate localization of rat Eag1 K+ channels is conferred by the proximal post-CNBHD region.
Chuang CC; Jow GM; Lin HM; Weng YH; Hu JH; Peng YJ; Chiu YC; Chiu MM; Jeng CJ
BMC Neurosci; 2014 Feb; 15():23. PubMed ID: 24495567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
